Skip to main content
Clinical Trials/NCT02529657
NCT02529657CompletedNot Applicable

Analysis of Effect of Low Level Laser Therapy in Spinal Surgery

University of Nove de Julho1 site in 1 country48 target enrollmentStarted: February 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
48
Locations
1
Primary Endpoint
Immunochemistry to evaluate low level laser therapy anti-inflammatory mechanism 24 hours

Study Overview

Brief Summary

Each year, more than one million individuals worldwide are submitted to laminectomies, with a failure rate higher than 40%. Postlaminectomy epidural adhesion is implicated as a main cause of ''failed back surgery syndrome'' and associated with increased risk of complications during revision surgery. The postoperative epidural scar can cause extradural compression or dural tethering, which results in recurrent radicular pain and physical impairment. Several studies in the literature are signalizing that Low-Level-Laser-Therapy (LLLT) is proven to be an effective tool to assist the inflammatory process and wound healing, as well to prevent infection. Thus, the objectives of this project are to delineate and evaluate the LLLT effects in spinal surgery. A prospective randomized, controlled trial with a total of 48 patients who underwent laminectomy, were divided into 2 groups. In the first group, 25 patients received LLLT during the surgical procedure over dura mater, over subcutaneous and on the skin, as well as 24h and 72h post surgery. In the second group, 23 patients were induced to think they will be getting the same treatment, although the laser is not operating. In those groups, C reactive protein, Lactate Dehydrogenase and Creatine kinase were evaluated in the second and fifth days after surgery, digital temperature will be measured and scores in visual analogue scale will be used, 5 minutes pre and 5 minutes post Laser application. The drainage output was collected in the first three days following surgery in both groups. Interleukins were evaluated in interstitial infiltrate drained in 24h and 48h. The data was evaluated for normality and subjected to appropriate statistical analysis, in order to seek representation, as same as the level of significance of the studied samples.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
10 Years to 90 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients undergoing to lumbar laminectomy

Exclusion Criteria

  • Active lumbar cancer
  • Infectious disease
  • Coagulation disorders
  • Dural injury during the surgery

Arms & Interventions

Placebo

Placebo Comparator

23 patients were induced to think they will be getting the same treatment, although the LLLT is not operating.

Intervention: Placebo (Procedure)

Low level Laser Therapy

Experimental

25 patients were submitted to spine surgery and have received low level laser therapy during surgery, 24 hours after surgery and 48 hours after surgery.

Intervention: Low Level Laser Therapy (Radiation)

Outcomes

Primary Outcomes

Immunochemistry to evaluate low level laser therapy anti-inflammatory mechanism 24 hours

Time Frame: 24 hours after surgery

Interstitial infiltrate obtained of Lumbar Drain collected 24 hours after surgery, interleukins IL-1, IL-4, IL-8, IL-10 and TNF alfa were measured through Immunochemistry, using ELISA.

Immunochemistry to evaluate low level laser therapy mechanism 48 hours after light delivery

Time Frame: 48h after surgery

Interstitial infiltrate was obtained of Lumbar Drain collected 48 hours after surgery, in this infiltrate interleukins IL-1, IL-4, IL-8, IL10 and TNF alfa were measured through Immunochemistry, using ELISA.

Secondary Outcomes

  • Score in Visual Analogue Scale(5 minutes post LLLT)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Vanessa Milanesi Holanda

MD, MS

University of Nove de Julho

Study Sites (1)

Loading locations...

Similar Trials